Analysts diverge on Ryman Healthcare target price

Analysts diverge on Ryman Healthcare target price
Ryman Healthcare plans for Mount Eliza, Australia. (Image: Supplied)
Gregor Thompson
Investment analysts who cover New Zealand Exchange-listed Ryman Healthcare are at odds with how they perceive the company's outlook.In a bullish note on NZ’s largest retirement village and aged care provider, released by Forsyth Barr on July 11, analysts Aaron Ibbotson and Benjamin Crozier wrote, "Ryman is one of the most attractive opportunities in New Zealand.”The analysts continued their “outperform” rating and set a 12-month target price of $7, almost double the trading price when the report was written.Sinc...

More Property

Former Serepisos property on the block again
Property

Former Serepisos property on the block again

The Miramar site is being sold by receivers less than two years after its mortgagee sale.

What's in a name? Du Val now Orange Pineapple
Property

What's in a name? Du Val now Orange Pineapple

The Du Val group has given its subsidiaries bizarre names such as Woodle.

Maria Slade 17 Jul 2024
Developer faces receivership and Serepisos action
Property

Developer faces receivership and Serepisos action

A Black Robin entity set up to develop alpine villas in Queenstown is the latest to fail.

Maria Slade 16 Jul 2024